The findings were particularly pronounced in individuals with dementia, pointing to a possible vascular benefit of higher BP.

A senior dog with dementia spent nearly one year waiting for a home — until a familiar face stepped in. The woman, who had been a foster parent to Ollie, “couldn’t stand the thought” of him going into ...

Social media users praised the woman's effort to take care of her cat, with one saying, "you're the best owner she could possibly ask for." ...

Dementia therapies may help relieve symptoms, but many different options are available. Some may help more than others.

“This drug takes the first new approach to schizophrenia treatment in decades,” Tiffany Farchione ... greater risk of death ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

SGLT2 inhibitors and dulaglutide are associated with comparable risk for dementia; however, it is uncertain whether these findings generalize to newer GLP-1 RAs.

Memory loss is the most well-known symptom of dementia, particularly Alzheimer’s disease. But experts say there are other ...

The University of Minnesota’s School of Public Health has launched a new research center to study and improve the treatment ...

Dementia is often thought of as a condition that primarily affects the elderly, linked closely with the aging process.

The safety and effectiveness of donanemab—an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA)—is ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.